Study Stopped
COVID-19 pandemic disrupted trial recruitment in 2020-2022. Cooperating healthcare centers lacked resources, and funding was exhausted, necessitating trial termination.
Psychotherapy for Young Adults With Mild-to-moderate Depression: Does Virtual Reality Increase Its Efficacy
PSYADEP
1 other identifier
interventional
12
1 country
2
Brief Summary
Cognitive Behavioral Therapy (CBT) is the most prestigious psychological treatment for depression. However, not only do we need to increase its efficacy but also to widen the repertoire of evidence-based psychotherapeutic interventions. The importance of the patient's engagement in treatment is highlighted in the literature as a key factor for a good therapeutic outcome over and above the type of therapy. In this sense, personal construct therapy (PCT), with some promising supporting evidence, is particularly suited to fit the personal values and attitudes of each patient. In contrast to CBT, PCT does not educate patients about depression and give them directions on the changes to be made in their dysfunctional behaviors or cognitions. Rather, PCT explores their coherence with respect to the person's sense of identity, their construction of self and others, and works with the conflicts or dilemmas that appear during this conjoint exploration using the Repertory Grid Technique (RGT). In this project, for the first time, the RGT will be implemented using Virtual Reality (VR). This format could be highly appealing for young people, thus facilitating their involvement in therapy. The efficacy of this innovative application of PCT using VR (PCT-VR) will be compared to usual PCT, and to CBT in a randomized clinical trial. The Beck Depression Inventory-II is the primary outcome measure for calculating both statistical and clinical significance, but other measures will also be used at pre-, post-therapy and six-month follow up. The trial will be done in a natural health context, mostly the usual primary care center of each patient, with those who consult during the active period of the study. Our research group has been working on both depression and personal construct theory for more than two decades (this includes our previous funded projects), particularly with a dilemma-focused intervention aimed to resolve the cognitive conflicts detected with the RGT. By fostering a technological innovation with VR, it is expected to boost the current efficacy of psychotherapy by increasing the engagement of young people and obtaining better outcomes. If these goals are met, a pathological evolution of the patient with its associated personal, health and social costs could be avoided.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Oct 2021
Typical duration for not_applicable depression
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2020
CompletedFirst Posted
Study publicly available on registry
March 25, 2020
CompletedStudy Start
First participant enrolled
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedDecember 9, 2024
December 1, 2024
1.8 years
February 18, 2020
December 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Beck depression inventory second edition
Beck Depression Inventory, Second Edition (BDI-II; Beck, Steer \& Brown, 1996). It is a 21-item self-report instrument to assess the existence and severity of symptoms of depression. Both the original and the Spanish version (Sanz, Perdigón, \& Vázquez, 2003) showed good psychometric properties and acceptability.
BDI-II is administered at the end of therapy (10 weeks), and 6-month follow-up
Secondary Outcomes (4)
Clinical Outcomes in Routine Evaluation-Outcome Measure
CORE-OM is administered at baseline, and then routinely every session (using short forms versions A and B) until the end of treatment (10 weeks), and 6-month follow-up
- Depression, Anxiety and Stress Scales
DASS-21 is administered at the end of therapy (10 weeks), and 6-month follow-up
Session Rating Scale 3.0
SRS 3.0 is administered routinely after every session, through intervention completion (10 weeks), and 6-month follow-up
Change Interview
administered at the end of therapy (10 weeks)
Other Outcomes (2)
Treatment adherence scale
Administered at the end of therapy (up to 1 year)
Consumer Reports Effectiveness Scale
administered at the end of therapy (10 weeks)
Study Arms (3)
Cognitive-behavioral therapy (CBT)
ACTIVE COMPARATORIndividual Cognitive Behavioral Therapy
Personal construct therapy (PCT)
EXPERIMENTALIndividual Personal Construct Therapy
Personal construct therapy with virtual reality (PCT-VR)
EXPERIMENTALIndividual Personal Construct Therapy with an immersive virtual reality app
Interventions
10 individual one-hour sessions, with one or two booster sessions at about three months after the tenth session
10 individual one-hour sessions, with one or two booster sessions at about three months after the tenth session
10 individual one-hour sessions, with one or two booster sessions at about three months after the tenth session
Eligibility Criteria
You may qualify if:
- All participants will meet diagnostic criteria for mild or moderate depressive episode according to ICD-10 (current version in the Catalan health system), diagnosed using MINI, and a score above 13 and below 29 on the BDI-II questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Barcelonalead
- Universitat Oberta de Catalunyacollaborator
Study Sites (2)
University of Barcelona
Barcelona, Catalonia, 08035, Spain
Associació Centre Higiene Mental Nou Barris
Barcelona, 08042, Spain
Related Publications (1)
Montesano A, Medina JC, Paz C, Garcia-Mieres H, Nino-Robles N, Garcia-Grau E, Crespillo JC, Garcia-Gutierrez A, Alabernia-Segura M, Feixas G. Does virtual reality increase the efficacy of psychotherapy for young adults with mild-to-moderate depression? A study protocol for a multicenter randomized clinical trial. Trials. 2021 Dec 13;22(1):916. doi: 10.1186/s13063-021-05809-1.
PMID: 34903251BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillem Feixas, Ph.D
University of Barcelona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- full professor
Study Record Dates
First Submitted
February 18, 2020
First Posted
March 25, 2020
Study Start
October 15, 2021
Primary Completion
July 31, 2023
Study Completion
July 31, 2024
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available after six months of study completion
- Access Criteria
- Researchers who provide a methodologically sound proposal whose proposed use of the data has been approved by an independent review committee
Individual participant data for all primary and secondary outcomes, after deidentification